Cited by 264Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

Guidotti, Alessandro, Auta, James, Davis, John M., Dong, Erbo, Grayson, Dennis R., Veldic, Marin, Zhang, Xianquan, Costa, Erminio·2005·Psychopharmacology

DOI 10.1007/s00213-005-2212-8

Open this paper in CoChat — free account

Abstract

Rationale Cortical gamma-aminobutyric acid (GABA)ergic neurons contribute to the orchestration of pyramidal neuron population firing as follows: (1) by releasing GABA on GABA(A) and GABA(B) receptors, (2) by releasing reelin in the proximity of integrin receptors located on cortical pyramidal neuron dendritic spines, and (3) through reelin contributing to the regulation of dendritic spine plasticity by modulating dendritic resident mRNA translation. In schizophrenia (SZ) and bipolar (BP) postmortem brains, the downregulation of mRNAs encoding glutamic acid decarboxylase 67 (GAD(67)) and reelin decreases the cognate proteins coexpressed in prefrontal cortex (PFC) GABAergic neurons. This finding has been replicated in several laboratories. Such downregulation suggests that the neuropil hypoplasticity found in the PFC of SZ and BP disorder patients may depend on a downregulation of GABAergic function, which is associated with a decrease in reelin secretion from GABAergic neuron axon terminals on dendrites, somata, or axon initial segments of pyramidal neurons. Indirectly, this GABAergic neuron downregulation may play a key role in the expression of positive and negative symptoms of SZ and BP disorders.Objectives The above described GABAergic dysfunction may be addressed by pharmacological interventions to treat SZ and BP disorders using specific benzodiazepines (BZs), which are devoid of intrinsic activity at GABA(A) receptors including alpha(1) subunits but that act as full positive allosteric modulators of GABA action at GABA(A) receptors containing alpha(2), alpha(3), or alpha(5) subunits. These drugs are expected to enhance GABAergic signal transduction without eliciting sedation, amnesia, and tolerance or dependence liabilities.Results and conclusions BZs, such as diazepam, although they are efficient in equilibrating GABA(A) receptor signal transduction in a manner beneficial in the treatment of positive and negative symptoms of SZ, may not be ideal drugs, because by mediating a full positive allosteric modulation of GABA(A) receptors containing the alpha(1) subunit, they contribute to sedation and to the development of tolerance after even a brief period of treatment. In contrast, other BZ-binding site ligands, such as 6-(2bromophenyl)-8-fluoro-4H-imidazo [1,5-a][1,4] benzodiazepine-3-carboxamide (imidazenil), which fail to allosterically and positively modulate the action of GABA at GABA(A) receptors with alpha(1) subunits but that selectively allosterically modulate cortical GABA(A) receptors containing alpha(5) subunits, contribute to the anxiolytic, antipanic, and anticonvulsant actions of these ligands without producing sedation, amnesia, or tolerance. Strong support for the use of imidazenil in psychosis emerges from experiments with reeler mice or with methionine-treated mice, which express a pronounced reelin and GAD(67) downregulation that is also operative in SZ and BP disorders. In mice that model SZ symptoms, imidazenil increases signal transduction at GABA(A) receptors containing alpha(5) subunits and contributes to the reduction of behavioral deficits without producing sedation or tolerance liability. Hence, we suggest that imidazenil may be considered a prototype for a new generation of positive allosteric modulators of GABA(A) receptors, which, either alone or in combination with neuroleptics, should be evaluated in GABAergic dysfunction operative in the treatment of SZ and BP disorders with psychosis.

Integrity signals

Registry

Crossref · 10.1007/s00213-005-2212-8

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
A framework for consciousness
Crick, F., & Koch, C. (2003) · Nature Neuroscience · doi:10.1038/nn0203-119 · Cited by 1,492
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,385
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,286
GABA A ‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D. G., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G. N., Pesold, C., Sharma, R. P., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,222
Self-citation
GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder
Benes, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00225-1 · Cited by 1,082
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs
DeFelipe, J., & Fariñas, I. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90015-7 · Cited by 975
Differences between somatic and dendritic inhibition in the hippocampus
Miles, R., Tóth, K., Gulyás, A. I., Hájos, N., & Freund, T. F. (1996) · Neuron · doi:10.1016/s0896-6273(00)80101-4 · Cited by 942

Show all 104 references

Research works printed but not linked: 2

Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L, Veldic M (2004) A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16:1–24
Peters A (1984) Chandelier cells. In: Jones EG, Peters A (eds) Cerebral cortex, vol 1. Plenum Press, NY, pp 361–380

Sorted by citations

Items 101–200 of 264

Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes
Eagleson, K. L., Gravielle, M. C., Schlueter, L. J., Russek, S. J., Farb, D. H., & Levitt, P. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.066 · Cited by 40
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse
Yin, W., Majumder, S., Clayton, T., Petrou, S., VanLinn, M. L., Namjoshi, O. A., Ma, C., Cromer, B. A., Roth, B. L., Platt, D. M., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.049 · Cited by 41
mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits
Maksymetz, J., Byun, N. E., Luessen, D. J., Li, B., Barry, R. L., Gore, J. C., Niswender, C. M., Lindsley, C. W., Joffe, M. E., & Conn, P. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109950 · Cited by 39
The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production
Danovich, L., Veenman, L., Leschiner, S., Lahav, M., Ben-Yosef, V. S., Weizman, A., & Gavish, M. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.04.005 · Cited by 38
Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage
Kadriu, B., Guidotti, A., Costa, E., & Auta, J. (2008) · Toxicology · doi:10.1016/j.tox.2008.11.021 · Cited by 37
Self-citation
The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline
Vinkers, C. H., Mirza, N. R., Olivier, B., & Kahn, R. S. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.513382 · Cited by 39
Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
Sahila, M. M., Babitha, P. P., Bandaru, S., Nayarisseri, A., & Doss, V. A. (2015) · Bioinformation · doi:10.6026/97320630011280 · Cited by 38
Selective α4β2 Nicotinic Acetylcholine Receptor Agonists Target Epigenetic Mechanisms in Cortical GABAergic Neurons
Maloku, E., Kadriu, B., Zhubi, A., Dong, E., Pibiri, F., Satta, R., & Guidotti, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.21 · Cited by 38
Self-citation
Behavioral Effects of the Benzodiazepine-Positive Allosteric Modulator SH-053-2’F-S-CH3 in an Immune-Mediated Neurodevelopmental Disruption Model
Richetto, J., Labouesse, M. A., Poe, M. M., Cook, J. M., Grace, A. A., Riva, M. A., & Meyer, U. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu055 · Cited by 39
Modeling “psychosis” in vitro by inducing disordered neuronal network activity in cortical brain slices
Aghajanian, G. K. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1484-9 · Cited by 42
Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia
Du, J., Duan, S., Wang, H., Chen, W., Zhao, X., Zhang, A., Wang, L., Xuan, J., Yu, L., Wu, S., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0844-z · Cited by 37
Modulatory effects of inhibition on persistent activity in a cortical microcircuit model
Konstantoudaki, X., Papoutsi, A., Chalkiadaki, K., Poirazi, P., & Sidiropoulou, K. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00007 · Cited by 34
Design, synthesis, and biological evaluation of fluorinated imidazo[1,2- a ]pyridine derivatives with potential antipsychotic activity
Marcinkowska, M., Kołaczkowski, M., Kamiński, K., Bucki, A., Pawłowski, M., Siwek, A., Karcz, T. P., Mordyl, B., Starowicz, G., Kubowicz, P., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.059 · Cited by 37
Oxidative stress parameters in diabetic rats submitted to forced swimming test: the clonazepam effect
Haeser, A. D. S., Sitta, Â., Barschak, A. G., Deon, M., Barden, A., Schmitt, G. O., Landgraff, S., Gomez, R., Barros, H. M. T., & Vargas, C. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.088 · Cited by 36
Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia
Bristow, G. C., Bostrom, J., Haroutunian, V. H., & Sodhi, M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.025 · Cited by 37
A Sensitive Period for GABAergic Interneurons in the Dentate Gyrus in Modulating Sensorimotor Gating
Guo, N., Yoshizaki, K., Kimura, R., Suto, F., Yanagawa, Y., & Osumi, N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0032-12.2013 · Cited by 36
Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia
Takahashi, S., Ukai, S., Kose, A., Hashimoto, T., Iwatani, J., Okumura, M., Tsuji, T., & Shinosaki, K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.033 · Cited by 36
Reelin-Haploinsufficiency Disrupts the Developmental Trajectory of the E/I Balance in the Prefrontal Cortex
Bouamrane, L., Scheyer, A. F., Lassalle, O., Iafrati, J., Thomazeau, A., & Chavis, P. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00308 · Cited by 34
Aberrant regulation of alternative pre-mRNA splicing in schizophrenia
Morikawa, T., & Manabe, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.08.012 · Cited by 34
Behavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
Miyamoto, Y., & Nitta, A. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r02cr · Cited by 32
HIV gp120‐induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK
Zhang, X., Green, M. V., & Thayer, S. A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14640 · Cited by 33
Self-citation
Involvement of Epigenetic Modifications of GABAergic Interneurons in Basolateral Amygdala in Anxiety-like Phenotype of Prenatally Stressed Mice
Zhu, C., Liang, M., Li, Y., Feng, X., Hong, J., & Zhou, R. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy006 · Cited by 32
Effects of Melatonin on Prenatal Dexamethasone-Induced Epigenetic Alterations in Hippocampal Morphology and Reelin and Glutamic Acid Decarboxylase 67 Levels
Lui, C., Hsu, M., Kuo, H., Chen, C.-C., Sheen, J., Yu, H., Tiao, M., Tain, Y., Chang, K., & Huang, L. (2015) · Developmental Neuroscience · doi:10.1159/000368768 · Cited by 32
Imidazenil: A low efficacy agonist at α1- but high efficacy at α5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem
Auta, J., Impagnatiello, F., Kadriu, B., Guidotti, A., & Costa, E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.002 · Cited by 32
Self-citation
BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia
Geffen, Y., Nudelman, A., Gil‐Ad, I., Rephaeli, A., Huang, M., Savitsky, K., Klapper, L. N., Winkler, I., Meltzer, H. Y., & Weizman, A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.002 · Cited by 33
The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice
Pibiri, F., Kozikowski, A. P., Pinna, G., Auta, J., Kadriu, B., Costa, E., & Guidotti, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807172105 · Cited by 31
Self-citation
Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review
Matrisciano, F., Panaccione, I., Grayson, D. R., Nicoletti, F., & Guidotti, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150713174242 · Cited by 31
Self-citation
GABA and Homovanillic Acid in the Plasma of Schizophrenic and Bipolar I Patients
Arrúe, A., Dávila, R., Zumárraga, M., Basterreche, N., Torres, M. Á. G., Goienetxea, B., Zamalloa, M. I., Anguiano, J. B., & Guimón, J. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0048-z · Cited by 31
GABA levels decline with age: A longitudinal study
Zuppichini, M. D., Hamlin, A. M., Zhou, Q., Kim, E., Rajagopal, S., Beltz, A. M., & Polk, T. A. (2024) · Imaging Neuroscience · doi:10.1162/imag_a_00224 · Cited by 31
Epigenetics of psychoactive drugs
Boyadjieva, N. I., & Varadinova, M. G. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01475.x · Cited by 30
Epigenetic Mechanisms in Psychiatric Diseases and Epigenetic Therapy
Karslı-Çeppioğlu, S. (2016) · Drug Development Research · doi:10.1002/ddr.21340 · Cited by 31
The GABABreceptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice
Wierońska, J. M., Kusek, M., Tokarski, K., Wabno, J., Froestl, W., & Pilc, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01301.x · Cited by 30
Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC)
Smith, M. D., Saunders, G. W., Clausen, R. P., Frølund, B., Krogsgaard‐Larsen, P., Larsson, O. M., Schousboe, A., Wilcox, K. S., & White, H. S. (2008) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.12.009 · Cited by 30
Glutamic Acid Decarboxylase Autoantibody Syndrome Presenting as Schizophrenia
Najjar, S., Pearlman, D. M., Zagzag, D., Golfinos, J. G., & Devinsky, O. (2012) · The Neurologist · doi:10.1097/nrl.0b013e318247b87d · Cited by 30
Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis
Petkova-Kirova, P. S., Rakovska, A., Corte, L., Zaekova, G., Radomirov, R., & Mayer, A. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.04.003 · Cited by 29
A Mutual Prodrug Ester of GABA and Perphenazine Exhibits Antischizophrenic Efficacy with Diminished Extrapyramidal Effects
Nudelman, A., Gil‐Ad, I., Shpaisman, N., Terasenko, I., Ron, H., Savitsky, K., Geffen, Y., Weizman, A., & Rephaeli, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7012453 · Cited by 29
Involvement of GABABReceptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4Receptor, LSP4-2022
Woźniak, M., Acher, F., Marciniak, M., Łasoń, M., Gruca, P., Papp, M., Pilc, A., & Wierońska, J. M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150516000630 · Cited by 28
Lmx1a Allows Context-Specific Isolation of Progenitors of GABAergic or Dopaminergic Neurons During Neural Differentiation of Embryonic Stem Cells
Nefzger, C. M., Su, C. T. E., Fabb, S. A., Hartley, B. J., Beh, S. J., Zeng, W. R., Haynes, J. M., & Pouton, C. W. (2012) · Stem Cells · doi:10.1002/stem.1105 · Cited by 27
Epigenetic Targets in GABAergic Neurons to Treat Schizophrenia
Costa, E., Dong, E., Grayson, D. R., Ruzicka, W. B., Simonini, M. V., Veldić, M., & Guidotti, A. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(06)54005-0 · Cited by 27
Self-citation
Dopaminergic modulation of tonic but not phasic GABAA-receptor-mediated current in the ventrobasal thalamus of Wistar and GAERS rats
Yagüe, J. G., Cavaccini, A., Errington, A. C., Crunelli, V., & Giovanni, G. D. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.023 · Cited by 26
Interplay of environmental signals and progenitor diversity on fate specification of cortical GABAergic neurons
Brandão, J. A., & Romcy-Pereira, R. N. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00149 · Cited by 29
Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation
Tanaka, S. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-41 · Cited by 26
Flattened Cone 2,8,14,20‐Tetrakis( L ‐valinamido)[4]resorcinarene: An Enantioselective Allosteric Receptor in the Gas Phase
Botta, B., Caporuscio, F., Subissati, D., Tafi, A., Botta, M., Filippi, A., & Speranza, M. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503987 · Cited by 26
Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study
Takagi, M., Ishigaki, Y., Uno, K., Sawada, S., Imai, J., Kaneko, K., Hasegawa, Y., Yamada, T., Tokita, A., Iseki, K., et al. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-76 · Cited by 25
Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning
Boschen, K. E., Keller, S. M., Roth, T. L., & Klintsova, A. Y. (2018) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.12.009 · Cited by 24
Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice
Guidotti, A., Dong, E., Tueting, P., & Grayson, D. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800977-2.00004-8 · Cited by 23
Self-citation
The association of excitation and inhibition signaling with the relative symptom expression of autism and psychosis-proneness: Implications for psychopharmacology
Ford, T. C., Abu-Akel, A. M., & Crewther, D. P. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.024 · Cited by 25
Overview of schizophrenia research and treatment in Pakistan
Nawaz, R., Gul, S., Amin, R., Huma, T., & Mughairbi, F. A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05545 · Cited by 23
Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits
Pei, J.-C., Liu, C., & Lai, W. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00126 · Cited by 26
Acute Imidazenil Treatment after the Onset of DFP-Induced Seizure Is More Effective and Longer Lasting than Midazolam at Preventing Seizure Activity and Brain Neuropathology
Kadriu, B., Guidotti, A., Costa, E., Davis, J. M., & Auta, J. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq356 · Cited by 23
Self-citation
Pharmacology of GABA and Its Receptors
Kaur, S., Singh, S., Arora, A., Ram, P., Kumar, S., Kumar, P., & Abed, S. N. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_8 · Cited by 23
Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE Study
Ramsey, T. L., Liu, Q., Massey, B. W., & Brennan, M. D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.008 · Cited by 22
Physiogenomic Analysis of Localized fMRI Brain Activity in Schizophrenia
Windemuth, A., Calhoun, V. D., Pearlson, G. D., Kocherla, M., Jagannathan, K., & Ruaño, G. (2008) · Annals of Biomedical Engineering · doi:10.1007/s10439-008-9475-2 · Cited by 22
Schizophrenia and the Epigenetic Hypothesis
Grayson, D. R. (2010) · Epigenomics · doi:10.2217/epi.10.22 · Cited by 22
Self-citation
The Potential of Cerebrolysin in the Treatment of Schizophrenia
Flores, G., & Atzori, M. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.57079 · Cited by 21
Stem cell therapy: social recognition recovery in a FASD model
Shirasaka, T., Hashimoto, E., Ukai, W., Yoshinaga, T., Ishii, T., Tateno, M., & Saito, T. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.111 · Cited by 22
Antipsychotic Subtypes Can be Characterized By Differences in their Ability to Modify Gabaergic Promoter Methylation
Dong, E., Grayson, D. R., Guidotti, A., & Costa, E. (2009) · Epigenomics · doi:10.2217/epi.09.2 · Cited by 21
Self-citation
Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors
Matrisciano, F., Dong, E., Nicoletti, F., & Guidotti, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00423 · Cited by 22
Self-citation
Synthesis, in Vivo Evaluation, and Molecular Modeling Studies of New Pyrazolo[5,1-c][1,2,4]benzotriazine 5-Oxide Derivatives. Identification of a Bifunctional Hydrogen Bond Area Related to the Inverse Agonism
Guerrini, G., Ciciani, G., Cambi, G., Bruni, F., Selleri, S., Guarino, C., Melani, F., Montali, M., Martini, C., Ghelardini, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801599a · Cited by 21
Epigenetic Targets in Schizophrenia Development and Therapy
Wawrzczak‐Bargieła, A., Bilecki, W., & Maćkowiak, M. (2023) · Brain Sciences · doi:10.3390/brainsci13030426 · Cited by 25
Monoamine modulation of tonic GABAA inhibition
Crunelli, V., & Giovanni, G. D. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0059 · Cited by 19
The biochemical womb of schizophrenia: A review
Gaur, N., Gautam, S., Gaur, M. C., Sharma, P., Dadheech, G., & Mishra, S. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0071-x · Cited by 19
The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons
Allison, J. G., Das, P. M., Ma, J., Inglis, F. M., & Jones, F. E. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.02.009 · Cited by 19
GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and increased reelin proteins in the hippocampus
Wierońska, J. M., Brański, P., Siwek, A., Dybała, M., Nowak, G., & Pilc, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.078 · Cited by 20
Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia
Umeda, K., Iritani, S., Fujishiro, H., Sekiguchi, H., Torii, Y., Habuchi, C., Kuroda, K., Kaibuchi, K., & Ozaki, N. (2016) · Synapse · doi:10.1002/syn.21924 · Cited by 20
Gene expression meta-analysis reveals the down-regulation of three GABA receptor subunits in the superior temporal gyrus of patients with schizophrenia
Frajman, A., Maggio, N., Muler, I., Haroutunian, V. H., Katsel, P., Yitzhaky, A., Weiser, M., & Hertzberg, L. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.027 · Cited by 20
Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders
Myint, A.-M., & Halaris, A. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.913303 · Cited by 18
Young Women do it Better: Sexual Dimorphism in Temporal Discrimination
Williams, L., Butler, J. S., Molloy, A., McGovern, E. M., Beiser, I., Kimmich, O., Quinlivan, B., O’Riordan, S., Hutchinson, M., & Reilly, R. B. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00160 · Cited by 17
Recurrent clozapine and lorazepam withdrawal psychosis with catatonia
Wang, B. Z., Gupta, A., Bastiampillai, T. J., & Sani, F. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412444992 · Cited by 17
Impaired GAD1 expression in schizophrenia‐related WISKET rat model with sex‐dependent aggressive behavior and motivational deficit
Büki, A., Horváth, G., Benedek, G., Ducza, E., & Kékesi, G. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12507 · Cited by 18
GABAA Receptor β2E155 Residue Located at the Agonist-Binding Site Is Involved in the Receptor Gating
Jatczak-Śliwa, M., Kisiel, M., Czyzewska, M. M., Brodzki, M., & Mozrzymas, J. W. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00002 · Cited by 16
Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia
Berretta, S., Heckers, S., & Benes, F. M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.019 · Cited by 15
A Neurochemical Basis for an Epigenetic Vision of Psychiatric Disorders (1996-2009)
Guidotti, A., & Grayson, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.026 · Cited by 14
Self-citation
Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia
O'Donovan, S. M., Franco, A. C. G., Ghisays, V., Caldwell, J. L., HAROUTUNIAN, V., Vinnedge, L. M. P., McCullumsmith, R. E., & Solomon, M. B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.010 · Cited by 14
“Clinician Knows Best”? Injustices in the Medicalization of Mental Illness
Gosselin, A. (2019) · Feminist Philosophy Quarterly · doi:10.5206/fpq/2019.2.7285 · Cited by 18
Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
Cai, H., Fu, X., Jiang, H., & Han, S. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00233-3 · Cited by 14
Neurocognitive Performance, Alcohol Withdrawal, and Effects of a Combination of Flumazenil and Gabapentin in Alcohol Dependence
Schacht, J. P., Randall, P. K., Waid, L. R., Baros, A. M., Latham, P. K., Wright, T. M., Myrick, H., & Anton, R. F. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01554.x · Cited by 14
Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium
Zhang, T., Li, J., Yu, H., Shi, Y., Li, Z., Wang, L., Wang, Z., Lu, T., Wang, L., Yue, W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198690 · Cited by 13
Psychosocial deficits across autism and schizotypal spectra are interactively modulated by excitatory and inhibitory neurotransmission
Ford, T. C., Crewther, D. P., & Abu-Akel, A. M. (2019) · Autism · doi:10.1177/1362361319866030 · Cited by 13
Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice
Romano, E., Angelis, F. D., Ulbrich, L., Jaco, A. D., Fuso, A., & Laviola, G. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3388-y · Cited by 14
Epigenetic Modifications in Neurological Diseases: Natural Products as Epigenetic Modulators a Treatment Strategy
Gangisetty, O., & Murugan, S. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_1 · Cited by 12
Quantitative analyses of [11C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain
Asai, Y., Ikoma, Y., Takano, A., Maeda, J., Toyama, H., Yasuno, F., Ichimiya, T., Ito, H., & Suhara, T. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32833019bf · Cited by 12
Stem cell therapy: a new approach to the treatment of refractory depression
Kigawa, Y., Hashimoto, E., Ukai, W., Ishii, T., Furuse, K., Tsujino, H., Shirasaka, T., & Saito, T. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1194-2 · Cited by 12
The involvement of GABAA receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment
Danovich, L., Weinreb, O., Youdim, M. B. H., & Silver, H. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000106 · Cited by 11
Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
Hulse, G. K., Kelty, E. A., Hood, S. D., Norman, A. F., Basso, M., & Reece, A. S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150619092720 · Cited by 11
Association study of the gamma-aminobutyric acid type a receptor γ2 subunit gene with schizophrenia
Zai, C. C. H., Tiwari, A. K., King, N. A., Luca, V. D., Müller, D. J., Shaikh, S. A., Wong, G., Meltzer, H. Y., Lieberman, J. A., & Kennedy, J. L. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.010 · Cited by 11
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans
Appel, L., Geffen, Y., Heurling, K., Eriksson, C., Antoni, G., & Kapur, S. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.07.009 · Cited by 11
Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia
Rentzsch, J., Stadtmann, A., Montag, C., Kunte, H., Plöckl, D., Hellweg, R., Gallinat, J., Kronenberg, G., & Jockers-Scherübl, M. C. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0616-y · Cited by 10
Absence of tolerance to the anticonvulsant and neuroprotective effects of imidazenil against DFP-induced seizure and neuronal damage
Kadriu, B., Gocel, J., Larson, J., Guidotti, A., Davis, J. M., Nambiar, M. P., & Auta, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.043 · Cited by 10
Self-citation
Antipsychotics promote GABAergic interneuron genesis in the adult rat brain: Role of heat-shock protein production
Kaneta, H., Ukai, W., Tsujino, H., Furuse, K., Kigawa, Y., Tayama, M., Ishii, T., Hashimoto, E., & Kawanishi, C. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.03.008 · Cited by 9
Molecular Dynamic Simulations to Probe Stereoselectivity of Tiagabine Binding with Human GAT1
Zafar, S., & Jabeen, I. (2020) · Molecules · doi:10.3390/molecules25204745 · Cited by 9
Neurochemistry of Autism
Folsom, T. D., & Fatemi, S. H. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_13 · Cited by 9
Functional Nutrition as Integrated Intervention for In- and Outpatient with Schizophrenia
Matrisciano, F. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230322160259 · Cited by 9
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers
Smith, R. C., Zhubi, A., Maloku, E., Sershen, H. W., Lajtha, Á., Davis, J. M., Costa, E., & Guidotti, A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1064 · Cited by 8
Self-citation
Restoring GABAergic Signaling and Neuronal Synchrony in Schizophrenia
Akbarian, S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081225 · Cited by 8
GRIN2A and Schizophrenia: Scientific Evidence and Biological Mechanisms
Sheng, X.-M., & Guan, W. (2024) · Current Neuropharmacology · doi:10.2174/011570159x327712241023084944 · Cited by 7
A novel approach to analyzing fMRI and SNP data via parallel independent component analysis
Liu, J., Pearlson, G. D., Calhoun, V. D., & Windemuth, A. (2007) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.709344 · Cited by 7
Modeling and Simulation of h GAT1: A Mechanistic Investigation of the GABA Transport Process
Zafar, S., Nguyen, M. E., Muthyala, R., Jabeen, I., & Sham, Y. Y. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.12.003 · Cited by 7
Sex-dependent sensitivity to positive allosteric modulation of GABA action in an APP knock-in mouse model of Alzheimer's disease: Potential epigenetic regulation
Auta, J., Locci, A., Guidotti, A., Davis, J. M., & Dong, H. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100025 · Cited by 8
Self-citation
Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine
Valvassori, S. S., da Rosa, R. T., Dal-Pont, G. C., Varela, R. B., Mastella, G. A., Daminelli, T., Fries, G. R., Quevedo, J., & Zugno, A. I. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10296 · Cited by 6

Authors: Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., Zhang, X., & Costa, E.
Affiliations: University of Illinois Chicago (US)
Corresponding author: Costa, Erminio
ORCID: Guidotti, Alessandro
Auta, James
Davis, John M.
Dong, Erbo
Grayson, Dennis R.
Zhang, Xianquan
Venue: Psychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2005-04-28
Volume: 180
Issue: 2
Pages: 191-205
ISSN: 0033-3158 (ISSN-L)
1432-2072
DOI: 10.1007/s00213-005-2212-8
OpenAlex: W2072551779
Cited by: 262
References: 104
Citations by year: 2026: 1 · 2025: 2 · 2024: 5 · 2023: 6 · 2022: 2 · 2021: 4 · 2020: 11 · 2019: 7 · 2018: 12 · 2017: 10 · 2016: 11 · 2015: 16 · 2014: 22 · 2013: 13 · 2012: 10
FWCI: 2.92
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Psychopharmacology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (R01MH6262A, R01MH062188, R01MH062090, R01MH62188, R01MH62090)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: schizophrenia, bipolar disorder, GABAergic dysfunction, GABAergic interneurons, reelin, GAD67, prefrontal cortex, benzodiazepines, positive allosteric modulation, GABAA receptor, alpha1 subunit, diazepam, sedation, drug tolerance, antipsychotic drugs, dendritic spine plasticity
MeSH terms: Reelin Protein, Animals, Benzodiazepines, Bipolar Disorder, Cerebral Cortex, gamma-Aminobutyric Acid, Glutamate Decarboxylase, Humans, Nerve Tissue Proteins, Synaptic Transmission, Receptors, GABA-A, Schizophrenia, Serine Endopeptidases, Cell Adhesion Molecules, Neuronal, Extracellular Matrix Proteins, Chloride Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks